USANA HEALTH SCIENCES INC (USNA) Stock Fundamental Analysis
USA - NYSE:USNA - US90328M1071 - Common Stock
30.51 USD
-0.35 (-1.13%)
30.51 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to USNA. USNA was compared to 36 industry peers in the Personal Care Products industry. USNA has an excellent financial health rating, but there are some minor concerns on its profitability. USNA is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year USNA was profitable.
In the past year USNA had a positive cash flow from operations.
Each year in the past 5 years USNA has been profitable.
In the past 5 years USNA always reported a positive cash flow from operatings.
1.2 Ratios
USNA has a better Return On Assets (4.64%) than 61.11% of its industry peers.
Looking at the Return On Equity, with a value of 6.42%, USNA is in the better half of the industry, outperforming 69.44% of the companies in the same industry.
USNA has a Return On Invested Capital (5.38%) which is in line with its industry peers.
USNA had an Average Return On Invested Capital over the past 3 years of 10.32%. This is below the industry average of 12.91%.
The 3 year average ROIC (10.32%) for USNA is well above the current ROIC(5.38%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.64% | ||
| ROE | 6.42% | ||
| ROIC | 5.38% |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
1.3 Margins
With a decent Profit Margin value of 3.79%, USNA is doing good in the industry, outperforming 63.89% of the companies in the same industry.
In the last couple of years the Profit Margin of USNA has declined.
Looking at the Operating Margin, with a value of 6.25%, USNA is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
USNA's Operating Margin has declined in the last couple of years.
USNA has a Gross Margin of 79.93%. This is amongst the best in the industry. USNA outperforms 94.44% of its industry peers.
In the last couple of years the Gross Margin of USNA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.25% | ||
| PM (TTM) | 3.79% | ||
| GM | 79.93% |
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
2. Health
2.1 Basic Checks
USNA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, USNA has less shares outstanding
Compared to 5 years ago, USNA has less shares outstanding
The debt/assets ratio for USNA is higher compared to a year ago.
2.2 Solvency
USNA has an Altman-Z score of 4.27. This indicates that USNA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.27, USNA is doing good in the industry, outperforming 72.22% of the companies in the same industry.
There is no outstanding debt for USNA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.27 |
ROIC/WACC0.63
WACC8.53%
2.3 Liquidity
A Current Ratio of 2.15 indicates that USNA has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.15, USNA is in line with its industry, outperforming 58.33% of the companies in the same industry.
A Quick Ratio of 1.47 indicates that USNA should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.47, USNA is in the better half of the industry, outperforming 63.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.47 |
3. Growth
3.1 Past
The earnings per share for USNA have decreased by -6.64% in the last year.
USNA shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.07% yearly.
The Revenue has been growing slightly by 2.75% in the past year.
USNA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.23% yearly.
EPS 1Y (TTM)-6.64%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%37.04%
Revenue 1Y (TTM)2.75%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%10.87%
3.2 Future
USNA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.49% yearly.
USNA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.12% yearly.
EPS Next Y2.78%
EPS Next 2Y15.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.33%
Revenue Next 2Y10.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 11.43, the valuation of USNA can be described as very reasonable.
USNA's Price/Earnings ratio is rather cheap when compared to the industry. USNA is cheaper than 88.89% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. USNA is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 8.80, which indicates a very decent valuation of USNA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of USNA indicates a rather cheap valuation: USNA is cheaper than 86.11% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of USNA to the average of the S&P500 Index (22.73), we can say USNA is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.43 | ||
| Fwd PE | 8.8 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, USNA is valued cheaper than 94.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.52 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
USNA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as USNA's earnings are expected to grow with 15.49% in the coming years.
PEG (NY)4.1
PEG (5Y)N/A
EPS Next 2Y15.49%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for USNA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
30.51
-0.35 (-1.13%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners58.05%
Inst Owner Change2.85%
Ins Owners0.61%
Ins Owner Change-0.18%
Market Cap557.42M
Analysts43.33
Price Target62.22 (103.93%)
Short Float %6.74%
Short Ratio5.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.3%
Min EPS beat(2)2.24%
Max EPS beat(2)34.35%
EPS beat(4)4
Avg EPS beat(4)19.49%
Min EPS beat(4)2.24%
Max EPS beat(4)34.35%
EPS beat(8)6
Avg EPS beat(8)17.25%
EPS beat(12)9
Avg EPS beat(12)21.2%
EPS beat(16)10
Avg EPS beat(16)13.82%
Revenue beat(2)2
Avg Revenue beat(2)1.7%
Min Revenue beat(2)0.66%
Max Revenue beat(2)2.74%
Revenue beat(4)3
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)2.74%
Revenue beat(8)4
Avg Revenue beat(8)-1.39%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)9
Avg Revenue beat(16)-0.74%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.8%
EPS NY rev (1m)0.38%
EPS NY rev (3m)0.38%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.98%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.79%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.43 | ||
| Fwd PE | 8.8 | ||
| P/S | 0.62 | ||
| P/FCF | N/A | ||
| P/OCF | 8.85 | ||
| P/B | 1.05 | ||
| P/tB | 2.28 | ||
| EV/EBITDA | 4.52 |
EPS(TTM)2.67
EY8.75%
EPS(NY)3.47
Fwd EY11.37%
FCF(TTM)-8.34
FCFYN/A
OCF(TTM)3.45
OCFY11.31%
SpS49.22
BVpS29.07
TBVpS13.36
PEG (NY)4.1
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.64% | ||
| ROE | 6.42% | ||
| ROCE | 9.17% | ||
| ROIC | 5.38% | ||
| ROICexc | 7.14% | ||
| ROICexgc | 18.89% | ||
| OM | 6.25% | ||
| PM (TTM) | 3.79% | ||
| GM | 79.93% | ||
| FCFM | N/A |
ROA(3y)9.11%
ROA(5y)13.39%
ROE(3y)12.23%
ROE(5y)18.88%
ROIC(3y)10.32%
ROIC(5y)15.36%
ROICexc(3y)25.77%
ROICexc(5y)39.61%
ROICexgc(3y)41.63%
ROICexgc(5y)58.84%
ROCE(3y)17.59%
ROCE(5y)26.19%
ROICexcg growth 3Y-27.3%
ROICexcg growth 5Y-19.15%
ROICexc growth 3Y-45.52%
ROICexc growth 5Y-31.11%
OM growth 3Y-18.51%
OM growth 5Y-10.85%
PM growth 3Y-20.58%
PM growth 5Y-12.29%
GM growth 3Y-0.21%
GM growth 5Y-0.29%
F-Score5
Asset Turnover1.22
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 613.46% | ||
| Cap/Sales | 23.95% | ||
| Interest Coverage | 84.38 | ||
| Cash Conversion | 69.02% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.15 | ||
| Quick Ratio | 1.47 | ||
| Altman-Z | 4.27 |
F-Score5
WACC8.53%
ROIC/WACC0.63
Cap/Depr(3y)385.75%
Cap/Depr(5y)273.18%
Cap/Sales(3y)9.41%
Cap/Sales(5y)6.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.64%
EPS 3Y-23.07%
EPS 5Y-10.07%
EPS Q2Q%37.04%
EPS Next Y2.78%
EPS Next 2Y15.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.75%
Revenue growth 3Y-10.36%
Revenue growth 5Y-4.23%
Sales Q2Q%10.87%
Revenue Next Year12.33%
Revenue Next 2Y10.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-33.36%
EBIT growth 3Y-26.96%
EBIT growth 5Y-14.62%
EBIT Next Year52.59%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-291.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-31.5%
OCF growth 3Y-20.46%
OCF growth 5Y-13.6%